These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3428530)

  • 41. [Organizational problems in the production of therapeutic preparations using donors' blood].
    Gavrilov OK; Rusanov VM
    Sov Med; 1983; (4):82-4. PubMed ID: 6867840
    [No Abstract]   [Full Text] [Related]  

  • 42. [Progress in modern hematology and transfusion].
    Gavrilov OK; Tokarev IuN; Matvienko VP
    Sov Med; 1982; (12):20-4. PubMed ID: 7163865
    [No Abstract]   [Full Text] [Related]  

  • 43. Past, present and forecast of transfusion medicine: What has changed and what is expected to change?
    Schmidt AE; Refaai MA; Blumberg N
    Presse Med; 2016; 45(7-8 Pt 2):e253-72. PubMed ID: 27474234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Challenges of transfusion medicine].
    Hervé P; Tiberghien P
    Rev Prat; 2001 Jun; 51(12):1337-40. PubMed ID: 11503508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood program and the possibility of applying red cell substitutes in Indonesia.
    Wikanta M
    Artif Cells Blood Substit Immobil Biotechnol; 1999 Jan; 27(1):43-8. PubMed ID: 10063437
    [No Abstract]   [Full Text] [Related]  

  • 46. [Various methods for good blood supply in Scandinavia].
    Oldinger E
    Nord Med; 1996 Sep; 111(7):212-8. PubMed ID: 8927533
    [No Abstract]   [Full Text] [Related]  

  • 47. Bibliography. Current world literature. Transfusion medicine.
    Curr Opin Hematol; 2001 Nov; 8(6):B140-51. PubMed ID: 11710320
    [No Abstract]   [Full Text] [Related]  

  • 48. [The transfusion of blood and blood substitutes in resuscitation].
    HOLLAENDER L
    Praxis; 1961 Oct; 50():1128-9. PubMed ID: 13908354
    [No Abstract]   [Full Text] [Related]  

  • 49. [The status and prospects for improvement in transfusion science in the Ukrainian SSR].
    Terekhov NT; Gutnik RB
    Klin Khir (1962); 1988; (3):1-4. PubMed ID: 3404818
    [No Abstract]   [Full Text] [Related]  

  • 50. [Successes and developmental prospects of molecular hematology and transfusion science].
    Gavrilov OK
    Probl Gematol Pereliv Krovi; 1979 Sep; 24(9):3-8. PubMed ID: 493270
    [No Abstract]   [Full Text] [Related]  

  • 51. [A system for direct blood transfusion].
    Dybok VG
    Voen Med Zh; 1965 Sep; 9():91. PubMed ID: 5878249
    [No Abstract]   [Full Text] [Related]  

  • 52. [Organization of oncological services in the USSR in the 10th Five-Year Plan (trends in development, planning and control)].
    Demidov VP
    Vopr Onkol; 1981; 27(8):3-11. PubMed ID: 7281590
    [No Abstract]   [Full Text] [Related]  

  • 53. [Discussion of the Current Report of the Presidium of the Academy of Medical Sciences of the USSR for 1976--1977 at the 40th Session of the AMN of the USSR which took place from April 4 til Aril 7, 1978].
    Shtykhno IuM
    Vestn Akad Med Nauk SSSR; 1979; (1):68-71. PubMed ID: 419865
    [No Abstract]   [Full Text] [Related]  

  • 54. [EXPERIENCE IN BLOOD TRANSFUSION, ITS COMPONENTS AND BLOOD SUBSTITUTES IN A RURAL DISTRICT HOSPITAL].
    PEREMYSHLENNIKOV II
    Probl Gematol Pereliv Krovi; 1964 Apr; 9():46-7. PubMed ID: 14198866
    [No Abstract]   [Full Text] [Related]  

  • 55. Oxygen carriers and transfusion medicine.
    Klein HG
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):123-35. PubMed ID: 8087236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Errors, hazards and mistakes in the indication for blood transfusion and infusion of blood substitutes].
    LEHMANN HD
    Bibl Haematol; 1963; 16():213-22. PubMed ID: 13929356
    [No Abstract]   [Full Text] [Related]  

  • 57. [Errors, hazards and mistakes in the indications for blood transfusion and infusion of blood substitutes].
    HENNEMANN HH
    Bibl Haematol; 1963; 16():195-206. PubMed ID: 13953759
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hazards due to technical reasons in the transfusion of blood and blood substitutes].
    HOLLANDER LP; WILLENEGGER H
    Bibl Haematol; 1963; 16():231-7. PubMed ID: 13961320
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter to the editor: What's in a name?
    Estep TN
    Artif Cells Blood Substit Immobil Biotechnol; 2011 Jun; 39(3):117; discussion 118. PubMed ID: 20636225
    [No Abstract]   [Full Text] [Related]  

  • 60. Research opportunities in transfusion medicine.
    Silberstein LE; Toy P
    JAMA; 2001 Feb; 285(5):577-80. PubMed ID: 11176862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.